SNAP Message Board - Msg: 14374789

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNAP

SNAP 7.800

+2.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (95)	9/13/2000 9:11:55 AM
From: RockyBalboa	Read Replies (1) of 124

SNAP release: finance.yahoo.com Synaptic Pharmaceutical to refocus business NEW YORK, Sept 13 (Reuters) - Synaptic Pharmaceutical Corp. (NasdaqNM:SNAP - news) said on Wednesday it will refocus its business plan to create more revenue in the short-term by making its intellectual property more widely available. The Paramus, N.J. company said it has formed exclusive relationships with other pharmaceutical companies in the past, limiting broad access to its technologies. The company uses gene data to help discover drugs. In March of this year, Synaptic began to make available non-exclusive licenses to some of its technologies and said it has received requests to sell the usage rights to others. In a separate release, the company said it would make available its ``universal functional assay'' for the identification of certain proteins. The company said it owns the rights to 107 issued patents and has 186 patent applications.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next